Ergomed (ERGO.L, ERGO LN)

  • 683.5
  • 50.8
  • 81.3
  • ERGOMED

    Closing Price (p): 1346.0

  • RATING 22/09/22

  • PREVIOUS RATING

Company Profile

Ergomed is a UK-listed healthcare services business operating across two divisions: Pharmacovigilance, which provides services relating to drug safety, and Clinical Research Services, which provides services relating to organising, executing and managing the clinical trial of drugs. The business is predominantly based in North America, and both divisions have high organic growth rates with a blended average above 10% per annum. High customer retention and order books provides strong visibility on growth and earnings streams.


Major Shareholders%
Reljanovic Miroslav17.9
Octopus Investments Ltd.11.7
Abrdn Investment Management7.5
BlackRock Invest. Mgt (UK) Ltd.4.1
Sand Grove Capital Management LLP4.0